Our approach offers the possibility of changing the natural immunodominance by pre-infection vaccination, focusing the responses on highly conserved epitopes more like those seen by long term non-progressors with HLA B27 or B57 (ref. [62]). The gene discussed is MRAP; the disease is infection.